Spero Therapeutics Inc (SPRO) is lower by Wednesday morning, with the stock decreasing -3.37% in pre-market trading to 1.72. SPRO's short-term technical score of 70 indicates that the stock has traded more bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 102 out of 146 industries, Spero Therapeutics Inc ranks higher than 83% of stocks. Spero Therapeutics Inc has risen 16.34% over the past month, closing at $1.51 on February 21. During this period of time, the stock fell as low as $1.47 and as high as $1.89. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
SPRO has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on SPRO!